General Information of Drug (ID: DM0AQ3D)

Drug Name
LMN-101
Indication
Disease Entry ICD 11 Status REF
Traveler's diarrhea ME05.1 Phase 2 [1]
Cross-matching ID
TTD ID
DSG73N

References

1 ClinicalTrials.gov (NCT04182490) A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Single Dose Regimen Study of LMN-101 in Healthy Volunteers Challenged With Campylobacter Jejuni. U.S.National Institutes of Health.